Patient Registry: Radio Frequency Ablation of Barrett's Esophagus Using HALO System
NCT ID: NCT02033070
Last Updated: 2014-01-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
OBSERVATIONAL
2013-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
HALO Patient Registry: Ablation of Barrett's Esophagus
NCT00848237
Micro-Layer Ablation of Barrett's Metaplasia- A Two-Phase, Multi-Center Trial - Extension of Follow-up to 5 Years
NCT00489268
Efficacy of CryoBalloon Focal Ablation System on Human Esophageal Barrett's Epithelium
NCT02249975
High Definition White Light Endoscopy and Narrow Band Imaging for the Assessment of Barrett's Disease After Endoscopic Therapy
NCT01360801
Ablation of Intestinal Metaplasia Containing Dysplasia
NCT00282672
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non-Dysplastic IM, LGD, HGD
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* received an ablation with the HALO Ablation System to treat Barrett's Esophagus (Retrospective)
* candidate agrees to proposed follow-up schedule of yearly surveillance following treatment
* signs consent
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ochsner Health System
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Virendra Joshi
Virendra Joshi, MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Virendra Joshi, MD
Role: PRINCIPAL_INVESTIGATOR
Oshsner Clinic Foundation and Medical Center-Kenner
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ochsner Medical Center
Kenner, Louisiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Barrett's RFA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.